Hilaryano Ferreira: Presented Our Meta-Analysis of LAAC Versus Oral Anticoagulation at ESC Congress
Hilaryano Ferreira, BLS Instructor at American Heart Association and American Stroke Association, Cardiologist at ULS Santa Maria, shared a post on LinkedIn:
“On Monday I presented our meta-analysis of left atrial appendage closure versus oral anticoagulation at ESC Congress in Munich.
Four randomised trials, 3,116 patients, spanning warfarin to contemporary DOACs. The efficacy signal was consistent across all of them (RR 0.79, I² 6%). The safety signal was not (I² 86%), and that heterogeneity is the finding, not the noise. It tracks the comparator era and how bleeding was defined.
Isolate the DOAC-era, post-ablation population in OPTION and LAAC cuts non-procedural bleeding at 36 months by more than half. Pool everything into one composite and that disappears.
Net clinical benefit is real. It is also context-dependent, and a single pooled endpoint hides more than it shows. CHAMPION-AF made the same point at scale: clearly less long-term bleeding, but a front-loaded procedural cost that has to be part of the conversation.
That same day I sat in on Dr Desiree Wussler talk, ‘Left atrial appendage occlusion after the hype: where are we?’ It was the clearest framing of the field I have heard.
CHAMPION-AF, the trials still running, the shift toward minimalist procedures, and an honest landing point: this is now a shared decision, not a fallback for patients who cannot take anticoagulation. That kind of synthesis is what clinicians need and rarely get.
I left Munich with more questions than I brought, and a clearer sense of where I want to spend the next few years answering them. If your centre is working on these, I would like to hear about it.
Thank you to my co-authors.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge